Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlanbia Regulatory News (GLB)

Share Price Information for Glanbia (GLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.52
Bid: 17.76
Ask: 19.10
Change: -0.77 (-4.01%)
Spread: 1.34 (7.545%)
Open: 19.20
High: 19.62
Low: 17.52
Prev. Close: 19.20
GLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

19 Jan 2011 07:00

RNS Number : 7132Z
Glanbia PLC
19 January 2011
 

 

Press

 

Corporate Communications Department

Glanbia House

Kilkenny

Ireland

Release

 

Telephone + 353 56 7772200

Facsimile + 353 56 7750834

www.glanbia.com

 

 

2010 FULL YEAR PRE CLOSE TRADING STATEMENT

 

Strong full year performance forecast

Reiterating guidance for circa 20% growth in adjusted earnings per share

 

19 January, 2011 - Glanbia plc, the international nutritional ingredients and cheese group, issues this pre close trading statement for the full year ended 1 January, 2011. In a separate press release today Glanbia announced the acquisition of Bio-Engineered Supplements and Nutrition (BSN®), a leading US performance nutrition business.

 

2010 performance

In the first half of 2010, Glanbia delivered excellent results, mainly due to a return to profitability in Irish Dairy Ingredients and a good performance by Global Nutritionals. In the second half of the year the positive trend continued, underpinned by stronger global dairy markets and solid demand across key nutritional sectors. Since the announcement of the Interim Management Statement in November 2010, the Group has performed broadly in line with expectations and Glanbia expects to deliver circa 20% growth in adjusted earnings per share for the full year. The full year impact of currency translation, relative to 2009, is largely neutral as expected.

 

Dairy Ireland

Dairy Ireland performed well in the second half with good revenue growth compared to the second half of 2009, primarily reflecting stronger dairy markets in Irish Dairy Ingredients. Operating profit performance continued to improve, underpinned by the sustained recovery in Irish Dairy Ingredients and the benefits of strategic cost reduction programmes in Ireland. The economic difficulties in Ireland continued to create a very challenging trading environment for Consumer Products and overall results for this business unit are expected to be lower than 2009. Agribusiness is expected to achieve a broadly similar outcome to 2009. Full year operating profit and margin for Dairy Ireland are forecast to be well ahead of 2009, which was a difficult year for this division.

 

US Cheese & Global Nutritionals

Building on a good first half performance, revenue in both US Cheese and Global Nutritionals grew strongly in the second half. This reflects improved US Cheese markets and strong volume growth in Global Nutritionals. Operating profit was comparable to the second half of 2009, as a good performance in Global Nutritionals was offset by a weaker performance in US Cheese. US Cheese' operating profit is expected to be lower than 2009, as performance was impacted by the refurbishment of the Twin Falls' cheese plant in the first half, higher milk price premiums during the course of the year and a sharp weakening in US cheese prices in the fourth quarter. In Global Nutritionals, volume growth continues to outpace market growth rates. This is expected to underpin higher operating profits for US Cheese & Global Nutritionals for the full year. Divisional operating margins are expected to be lower following higher input costs and significant brand and people investment by Global Nutritionals during the year.

 

Joint Ventures & Associates

Joint Ventures & Associates are expected to have a reasonable year with results forecast to be similar to 2009. The 40% expansion of Southwest Cheese was completed on time and on budget and was fully commissioned in 2010. Southwest Cheese is forecast to deliver a solid performance for the year despite the adverse effect of volatile cheese markets in the fourth quarter. Glanbia Cheese in the UK and Nutricima in Nigeria are expected to perform broadly in line with expectations.

 

2010 exceptional pension credit

The Group undertook a strategic review of pension arrangements during 2009 which resulted in a significant reduction in pension liabilities. In 2010, further revisions to the Group's pension arrangements for three additional Irish pension schemes have been finalised. This will give rise to a further net reduction in pension liabilities resulting in an exceptional credit of approximately €10 million in 2010.

 

2010 net debt

Glanbia is forecasting 2010 year-end net debt of approximately €420 million.

 

Outlook

In line with previous guidance, Glanbia reiterates its 2010 adjusted earnings per share growth, which is expected to be approximately 20%.

 

Inclusive of the benefits of the BSN acquisition announced today, Glanbia is forecasting adjusted earnings per share growth (on a constant currency basis) for 2011 of 11% to 13%.

 

Glanbia expects to announce 2010 full year results at 07:00am on Wednesday, 2 March 2010.

 

ENDS

 

 

About Glanbia plc

Glanbia plc is an international nutritional ingredients and cheese group, headquartered in Ireland. Glanbia has over 4,000 employees worldwide, including Joint Ventures and Associates. The Group has three business segments - US Cheese & Global Nutritionals, Dairy Ireland and Other Business. Glanbia also has three principal international joint ventures - Southwest Cheese in the USA, Glanbia Cheese in the UK and Nutricima in Nigeria - as well as a number of small Irish-based joint ventures and associates. Glanbia is listed on the Irish and London Stock Exchanges (Symbol: GLB).

 

Cautionary statement

This announcement contains "forward-looking statements". These statements have been made by the directors in good faith based on the information available to them up to the time of their approval of this announcement. Due to the inherent uncertainties, including both economic and business risk factors, underlying such forward-looking information, actual results may differ from those expressed or implied by these forward-looking statements. Further no obligation is undertaken to update any forward-looking statements in this announcement.

 

For further information contact Glanbia plc on +353 56 777 2200

Siobhan Talbot, Group Finance Director

Geraldine Kearney, Corporate Communications Director + 353 87 231 9430

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUMGGUPGUQB
Date   Source Headline
27th Jun 20247:00 amRNSCompletion of Buyback
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 202410:45 amRNSDirector/PDMR Shareholding
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20243:13 pmRNSTotal Voting Rights
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20245:21 pmRNSTransaction in Own Shares
24th May 202410:53 amRNSHolding(s) in Company
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 202412:47 pmRNSDirector/PDMR Shareholding
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20243:00 pmRNSDirectorate Change
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
8th May 202412:24 pmRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 202410:16 amRNSDirectorate Change
1st May 20244:35 pmRNSResult of AGM
1st May 20247:00 amRNSFirst Quarter 2024 IMS
1st May 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.